Skip to content
DraconiticResearch
Search Sources API
190,839 studies31 sourcesUpdated 55 min ago
Peer-reviewedCC BY 4.0Frontiers in Microbiology

Predicting clinically actionable metagenomic next-generation sequencing in sepsis through dynamic inflammatory trajectories

  • Xiaocheng Ding1
  • Peng Bao1
  • Xiaopeng Huang1
  • Rui Xu1
  • Xinyi Tang1
  • Yuzhi Wu1
  • Xiaoli Cui1
  • Yang Lu1
  1. 1Department of Intensive Care Medicine, Affiliated Hospital of Nantong University, Nantong
Read full textPDFDOICite

Abstract

Background: Metagenomic next-generation sequencing (mNGS) improves pathogen detection in sepsis, but positive results do not always prompt antimicrobial modification. We investigated whether dynamic host-response trajectories during the mNGS peri-report interval could predict clinical actionability.

Methods: This retrospective single-center study included 109 adults with sepsis who underwent mNGS and conventional culture, and 72 patients with complete prespecified predictor data entered model development. Baseline and dynamic logistic models were assessed for discrimination, calibration, prediction error, and exploratory decision-curve performance. Final fixed models underwent 1,000-resample bootstrap optimism correction.

Results: mNGS positivity was 94.8% in the actionable group and 84.3% in the non-actionable group, with broader descriptive pathogen detection than culture. In the complete-case cohort, the peri-report change in white blood cell count (dWBC) remained associated with actionability after adjustment for the included baseline variables (adjusted OR, 1.14; 95% CI, 1.02–1.28; P = 0.025). Apparent AUC increased from 0.744 to 0.816 after adding dWBC. Optimism-corrected AUCs were 0.697 and 0.768, and corrected Brier scores were 0.228 and 0.207. No baseline-WBC interaction was detected ( P = 0.494).

Conclusion: A less pronounced decline or an increase in WBC from pre-mNGS sampling to post-report reassessment was associated with a greater likelihood of subsequent documented mNGS-related antimicrobial modification.

Related

  1. Engineering clinically actionable nanomedicine for cancer immunometabolic ecosystem reprogramming
    Yuhong Gao, Xiulin Dong, Sijia Hua +3
    EBioMedicinePeer-reviewedCC BY-NCFull textOncologyEurope PMCCrossref
  2. Pan-cancer analysis identifies nine conserved miRNA regulators of tumor cytolytic activity and clinically actionable immune targets
    N. Bagherlou, S. Aliyari, Z. Salehi +2
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. Why Circulating Interleukin‐6 Is Not Yet a Standalone Clinically Actionable Biomarker in HFrEF: A Context‐of‐Use Review
    Yongxin Ye, Martina Colombo, Jennifer Meessen +9
    European journal of clinical investigationPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Clinically Actionable Prevention and Management of Major Complications During Durable Left Ventricular Assist Device Support: A Contemporary Narrative Review
    Wei Yong Sheng, Tian Sheng Tang, You Shi Wu +3
    Cardiology researchPeer-reviewedCC BYFull textCardiovascular medicineEurope PMCPMC
  5. Artificial Intelligence in Gastroenterology: Towards Explainable, Generalisable and Clinically Actionable Decision Support.
    İsmail Baydili, Burak Tasci, Sengul Dogan +1
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMC

Cite

BibTeXRIS
BibTeX
@article{ding2026predicting,
  title = {{Predicting clinically actionable metagenomic next-generation sequencing in sepsis through dynamic inflammatory trajectories}},
  author = {Xiaocheng Ding and Peng Bao and Xiaopeng Huang and Rui Xu and Xinyi Tang and Yuzhi Wu and Xiaoli Cui and Yang Lu},
  journal = {Frontiers in Microbiology},
  year = {2026},
  month = oct,
  doi = {10.3389/fmicb.2026.1949602},
  url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.1949602/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Predicting clinically actionable metagenomic next-generation sequencing in sepsis through dynamic inflammatory trajectories
AU  - Xiaocheng Ding
AU  - Peng Bao
AU  - Xiaopeng Huang
AU  - Rui Xu
AU  - Xinyi Tang
AU  - Yuzhi Wu
AU  - Xiaoli Cui
AU  - Yang Lu
PY  - 2026
DA  - 2026/10/20
JO  - Frontiers in Microbiology
DO  - 10.3389/fmicb.2026.1949602
UR  - https://www.frontiersin.org/articles/10.3389/fmicb.2026.1949602/full
AB  - Background: Metagenomic next-generation sequencing (mNGS) improves pathogen detection in sepsis, but positive results do not always prompt antimicrobial modification. We investigated whether dynamic host-response trajectories during the mNGS peri-report interval could predict clinical actionability.  Methods: This retrospective single-center study included 109 adults with sepsis who underwent mNGS and conventional culture, and 72 patients with complete prespecified predictor data entered model development. Baseline and dynamic logistic models were assessed for discrimination, calibration, prediction error, and exploratory decision-curve performance. Final fixed models underwent 1,000-resample bootstrap optimism correction.  Results: mNGS positivity was 94.8% in the actionable group and 84.3% in the non-actionable group, with broader descriptive pathogen detection than culture. In the complete-case cohort, the peri-report change in white blood cell count (dWBC) remained associated with actionability after adjustment for the included baseline variables (adjusted OR, 1.14; 95% CI, 1.02–1.28; P = 0.025). Apparent AUC increased from 0.744 to 0.816 after adding dWBC. Optimism-corrected AUCs were 0.697 and 0.768, and corrected Brier scores were 0.228 and 0.207. No baseline-WBC interaction was detected ( P = 0.494).  Conclusion: A less pronounced decline or an increase in WBC from pre-mNGS sampling to post-report reassessment was associated with a greater likelihood of subsequent documented mNGS-related antimicrobial modification.
SN  - 1664-302X
ER  -